Want to Subscribe?
Read Corporate India and add to your Business Intelligence

Unlock Unlimited Access
Published: July 15, 2023
Updated: July 15, 2023
BSE ticker code | 543599 |
NSE ticker code | KSOLVES |
Major activity | Computer-Software & consulting |
Managing Director | Ratan Kumar Srivastava |
Equity capital | Rs. 11.86 crore; FV Rs. 10 |
52 week high/low | Rs. 1120 / Rs. 356 |
CMP | Rs. 1067.60 |
Market Capitalisation | Rs. 1265.75 crore |
Recommendation | Accumulate at declines |
Noida-headquartered Ksolves India is a small cap (market cap Rs 1,000 crore) information technology company that specialises in providing a range of software development and IT consulting services to various industries, including e-commerce, healthcare and finance. The company promises to be a true software development partner for the customer’s business. It curates and develops the best possible software solutions while keeping the customer’s original brief and business needs in mind. It comes with a proven track record of servicing clients across several countries with 40+ in-house technology experts.
While it is a 360-degree software development provider, it is known in the industry for its expertise in Big Data (Apache Katka, Apache Nifi, Apache Spark, Apache Cassandra), its sales force, DevOps, Java, Data Science (Artificial Intelligence and Machine Building), Microservies, openshift penetration, testing, etc. It also has a strong presence in developing and distributing apps on the Adoo and Magento platforms.
The company is small in size. Even after 10 years of its existence, its turnover has not yet reached the Rs 100-crore mark and the net profit has not exceeded Rs 15 crore. However, its profit margins are superb and after going public in fiscal 2020, its earning per share was Rs 21. The company’s ROE and ROCE are 110.54 per cent and 138.50 per cent respectively. The top management is shareholder-friendly and spends most of the earnings on dividend payments, the payout ratio standing at 74 per cent. For the last year ended March 2023, it has paid a dividend of Rs 15.50 per share; i.e., 155 per cent.
Ksolves has made rapid strides on the financial front, with compounded average sales growth during the last five years being 83 per cent and profit growing at a CAGR of 234 per cent. What is more, prospects are all the more encouraging going ahead. Consider:
The share price of Ksolves has now shot up to cross the Rs 1,000 mark. In view of the company’s rising profitability and improving EPS, the share price is also expected to rule strong.
PERFORMANCE INDICATORS (Rs. in crore)
Year | Net Sales | Net Profit | EPS (Rs.) | Div (%) | BV (%) | RONW (%) |
---|---|---|---|---|---|---|
2020-21 | 24.00 | 8.00 | 6.64 | 45.0 | 83.67 | 64.33 |
2021-22 | 45.00 | 15.00 | 13.02 | 30.0 | 13.83 | 93.15 |
2022-23 | 78.31 | 24.72 | 20.90 | 110.0 | 18.90 | 126.58 |
BSE ticker code | 590006 |
NSE ticker code | AMRUTANJAN |
Major activity | Pharmaceuticals |
Chairman | Sambhu Prasad Sivalenka |
Equity capital | Rs. 2.92 crore; FV Re. 01 |
52 week high/low | Rs. 850 / Rs. 552 |
CMP | Rs. 732.25 |
Market Capitalisation | Rs. 2140.41 crore |
Recommendation | Buy at declines |
Chennai-headquartered and 130-year old Amrutanjan Healthcare is one of the oldest Ayurvedic and OTC brands. The core focus of the company is to create a niche for itself with a strong portfolio of affordable healthcare, personal and hygiene care products in a highly competitive market. Thanks to its flagship brand – Amrutanjan Pain Balm — the company is a household name in India.
The company was promoted in 1983 by social reformer, journalist and freedom fighter Desodharka Sri Nageshwara Rao Pantulu Guru. The Amrutanjan brand has now been repositioned with ‘Pure Healthy Essence’ as its corporate promise to consumers. Apart from the popular pain balm, the company has been constantly expanding its product portfolio with a range of pain management products (aromatic balms, creams and sprays for headaches and bodyaches. The company also has a presence in premium category products under its sub-brand ‘Roll-on’, and has launched brand ‘Relief’ which caters to congestion-related issues like cold rubs, nasal inhalers, lozenges and cough syrups. It is now taking action to focus on the competency of each product and its application. From R&D to branding to advertising, Amrutanjan is positioning itself as a specialist in a competitive scenario.
With a view to diversifying its product range, Amrutanjan Healthcare in 2015 entered the field of sanitary napkins under the brand name ‘Comfy’, and positioned it as an affordable alternative for a larger target audience.
The company has also entered the business of soft drinks with the acquisition of Siva’s Soft Drink Pvt Ltd whose flagship pulp-based flavoured fruit drink brand ‘Fruitnik’ has an annual revenue of around Rs 20 crore.
Amrutanjan has been growing slowly but steadily on financial front. During the last 12 years, its sales turnover has advanced more than three times – from Rs 128 crore in fiscal 2012 to Rs 380 crore in fiscal 2023, with operating profit more than doubling from Rs 20 crore to Rs 44 crore and the profit at net level more than trebling from Rs 12 crore to Rs 40 crore. Going ahead, prospects for the company are all the more promising. Consider:
Shares of the company are quoted around Rs 725. Discerning investors will do well to include these stocks in their portfolio.
PERFORMANCE INDICATORS (Rs. in crore)
Year | Net Sales | Net Profit | EPS (Rs.) | Div (%) | BV (%) | RONW (%) |
---|---|---|---|---|---|---|
2019-20 | 261.50 | 25.10 | 8.60 | 210.0 | 54.50 | 16.40 |
2020-21 | 332.80 | 61.10 | 20.90 | 420.0 | 73.70 | 32.60 |
2021-22 | 405.80 | 67.20 | 23.00 | 460.0 | 90.70 | 28.00 |
2022-23 | 379.64 | 39.83 | 13.60 | 360.0 | 99.50 | 27.95 |
BSE ticker code | 530555 |
NSE ticker code | -- |
Major activity | Cable - Electricals |
Managing Director | Sanjay Aggarwal |
Equity capital | Rs. 38.84; FV Rs. 02 |
52 week high/low | Rs. 45 / Rs. 10 |
CMP | Rs. 35.79 |
Market Capitalisation | Rs. 694.98 crore |
Recommendation | Buy at declines |
New Delhi-headquartered Paramount Communications (originally known as Paramount Cables Corporation) is one of India’s leading wire and cable manufacturing companies with over six decades of operations. The company is part of the Paramount Cable group which was promoted by the late Shyam Sunder Aggarwal way back in 1955. The group has built up a portfolio spanning a comprehensive range of high voltage (HV) and low voltage (LV) power cables, optical fibre cables and other telecom cables, railway cables, specialized cables, instrumentation and data cables, and fire survival cables, among others. Paramount Cables has a prestigious clientele that includes government, institutional and major private sector organisations – both national and international — in the power, telecom, railways, IT and communication, construction, defence and space research sectors, among others.
With a focus on manufacturing excellence, technological advancement and customer satisfaction, the company continues to meet and exceed global quality benchmarks and provide total cabling solutions for its customers.
Paramount has a strong export base, having executed orders for reputed international corporations and agencies in various countries, including the UK, Spain, Russia, South Africa, the UAE, Jordan, Oman, Kuwait, Qatar, Iraq, Sri Lanka, Ukraine, Chile, Tanzania, Ghana, Kenya, Zambia, Nepal, Bangladesh and Nigeria.
However, there is nothing worth writing home about the financial performance of the company. During the last 12 years, sales and profits have moved in an irregular fashion. The sales turnover had declined from Rs 713 crore in fiscal 2012 to Rs 677 crore in fiscal 2013 and further to Rs 308 crore in fiscal 2016. But thereafter it has recorded Rs 433 crore in fiscal 2018 and furthermore Rs 796 crore in fiscal 2023. Likewise, on the earning front the operating profit was negative till fiscal 2018, with the loss amounting to Rs 14 crore in fiscal 2012, rising to Rs 20 crore in fiscal 2014 and further rising to Rs 48 crore in fiscal 2017. But it came into the black with a profit of Rs 42 crore in fiscal 2019, which improved to Rs 48 crore in fiscal 2023. Interestingly, the company has started doing well for the last two years or so. What is more, its prospects are quite encouraging going ahead.
Paramount caters to a diverse range of industries, including telecommunication, railways, space research, thermal and nuclear power plants, petrochemical, fertilisers and electronics, which require a wide range of technically advanced cables, cords and wires. All these industries are doing quite well at present and hence their demand for Paramount products is steadily going up. This means there are bright chances for the improvement of the company’s topline as well as bottomline.
Paramount shares with a face value of Rs 2 are quoted around Rs 34/35. In view of the recent improvement and better outlook going ahead for the company, discerning investors can certainly invest in this scrip.
PERFORMANCE INDICATORS (Rs. in crore)
Year | Net Series | Net Profit | EPS (Rs.) | Div (%) | BV (%) | RONW (%) |
---|---|---|---|---|---|---|
2019-20 | 606.20 | 26.34 | 1.53 | -- | 9.89 | 14.46 |
2020-21 | 591.08 | 3.10 | 0.17 | -- | 9.94 | 1.61 |
2021-22 | 580.94 | 8.21 | 0.42 | -- | 10.39 | 4.07 |
2022-23 | 796.47 | 47.77 | 2.40 | -- | 15.20 | 16.19 |
February 15, 2025 - First Issue
Industry Review
Want to Subscribe?
Read Corporate India and add to your Business Intelligence
Unlock Unlimited Access
Lighter Vein
Popular Stories
Archives